Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Risk of Cancer in 767 Patients with Giant Cell Arteritis in Western Norway: A Retrospective Cohort with Matched Controls.

Brekke LK, Fevang BS, Diamantopoulos AP, Assmus J, Esperø E, Gram Gjesdal C.

J Rheumatol. 2019 Jul 15. pii: jrheum.190147. doi: 10.3899/jrheum.190147. [Epub ahead of print]

PMID:
31308209
2.

Survival and death causes of patients with giant cell arteritis in Western Norway 1972-2012: a retrospective cohort study.

Brekke LK, Fevang BS, Diamantopoulos AP, Assmus J, Esperø E, Gjesdal CG.

Arthritis Res Ther. 2019 Jun 25;21(1):154. doi: 10.1186/s13075-019-1945-4.

3.

Increased Incidence of Giant Cell Arteritis in Urban Areas?

Brekke LK, Fevang BT, Myklebust G.

J Rheumatol. 2019 Mar;46(3):327-328. doi: 10.3899/jrheum.180714. Epub 2019 Jan 15. No abstract available.

PMID:
30647168
4.

Correction to: Incidence of giant cell arteritis in Western Norway 1972-2012: a retrospective cohort study.

Brekke LK, Diamantopoulos AP, Fevang BT, Aβmus J, Esperø E, Gjesdal CG.

Arthritis Res Ther. 2018 Dec 7;20(1):271. doi: 10.1186/s13075-018-1781-y.

5.

Incidence of giant cell arteritis in Western Norway 1972-2012: a retrospective cohort study.

Brekke LK, Diamantopoulos AP, Fevang BT, Aβmus J, Esperø E, Gjesdal CG.

Arthritis Res Ther. 2017 Dec 15;19(1):278. doi: 10.1186/s13075-017-1479-6. Erratum in: Arthritis Res Ther. 2018 Dec 7;20(1):271.

Supplemental Content

Loading ...
Support Center